Unravelling the molecular mechanisms that govern the maintenance of pluripotency in hESCs and mESCs by Garcia Serra, Anna & Universitat Autònoma de Barcelona. Facultat de Biociències
Self-renewal
Differentiation
Anna García Serra       - Degree in Biochemistry          - Tutor: Mireia Duñach
Unravelling the molecular mechanisms that govern 
the maintenance of pluripotency in hESCs and mESCs
To determine pluripotency in ESCs multiple pieces interplay to form a complex and integrated functioning
network. There is a fine-tuned control of the pluripotency machinery at many regulatory levels, where
various players are involved. The differences of pluripotency regulation between hESCs and mESCs have
to be highlighted, as well as the flexibility in the pluripotency governance factors in some cases as an
evolutionary advantage. Further studies on pluripotent stem cells will be of interest for a better
understanding of developmental biology and cancer regulation and eventually could be applied to new
regenerative medicine technologies or generation of patient-specific induced pluripotent stem cells.
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Conclusions and future perspectives
Objective: a current state-of-the-art review 
Pluripotency is defined as a dual property of self-renewal and differentiation potential
that is progressively lost as lineage commitment and development occur. The
maintenance of pluripotency is guaranteed by the sustainment of self-renewal and the
suppression of differentiation processes (Figure 1). Pluripotency is not a unique static
state. In fact, murine and human embryonic stem cells (mESCs and hESCS respectively)
represent different pluripotent states. The molecular mechanisms which cooperate to
maintain the undifferentiated state in both ESCs are described below.
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Figure 1. Schematic diagram
of the two processes that are
necessarily regulated to
achieve the pluripotent state.
Figure 2. Representation of the differences in the pluripotent
state regulation by extrinsic factors and their signaling
pathways between mouse ESCs (mESCs, above) and human
ESCs (hESCS below). Image modified from reference 4.
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Oct4, Sox2 and Nanog are the
three transcription factors in
charge of specific gene
expression for maintaining the
pluripotency. This triumvirate
is self-regulated by a positive
auto-regulatory loop and
integrates the signalling
pathways with the expression
of key pluripotent genes by a
multiprotein complex based
on Oct4-Sox2 heterodimer
able to recruit Polymerase II.
MicroRNAs prevent specific
translation of their target
mRNAs. They are essential
post-transcriptional regulators
as they contribute to
pluripotency maintenance,
proliferation and early
development. ESCs express a
small subset of unique
microRNAs that belong to
miR-371, miR-302, miR-17,
miR-106, and let-7 families.
The epigenetic landscape
determines the transcriptional
outcome of a cell. Epigenetic
machinery displays regulatory
mechanisms by which signaling
cascades can directly regulate
histone modifications and
chromatin modifying enzymes.
Pluripotency gene expression is
activated while developmental
genes are repressed, but
poised.
Extrinsic signals can be
propagated through
intracellular signal transduction
pathways. Extracellular signals
contribute either to
maintenance of pluripotency or
the stimulation of
differentiation. The extrinsic
mechanisms that modulate
stem-cell self-renewal in
humans are different from
those in mice. The consensus
factors are shown in Figure 2.
